This major report was produced by the WHO's Advisory Committee on Health Research - after wide consultation - to highlight the relevance of genomics for global healthcare, with a particular focus on the implications for developing countries. It aims to ensure that genome technology is used to reduce rather than exacerbate global inequalities in health status.

The report focuses on human and pathogen genomics but also acknowledges the potential benefits of plant and animal genomics. Some of the issues surrounding the impact of genomics in developing countries are highlighted, for example, the high cost of genomic research, intellectual property rights and the way in which the pharmaceutical industry operates.

The report concludes with a series of recommendations for genomics and health in WHO member states, focusing in particular on the ways in which international cooperation may provide greater universal benefit of genomics research and technologies. The report is a useful resource, overviewing many aspects of genomics and the implications for healthcare in the future.

Go to key document